Skip to main content
Signal8

Kiu Cu Seng

SEC insider (Form 3/4/5 filer). CIK 0001891617. Officer at ARC Group Acquisition I Corp. (ARCL) and 1 other issuer. 1 reported Form 4/5 transaction since Sep 2024; latest on Nov 12, 2025. Located in BERKELEY HEIGHTS, NJ.

Companies Kiu Cu Seng has filed insider reports for

  • ARC Group Acquisition I Corp. (ARCL): Officer, See remarks
  • Cyclacel Pharmaceuticals, Inc. (CYCC): Director, Officer, CFO and Secretary
Kiu Cu Seng profile photo

Kiu Cu Seng

CIK: 0001891617

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ARC Group Acquisition I Corp. logo
ARCL

ARC Group Acquisition I Corp.

Officer
Cyclacel Pharmaceuticals, Inc. logo
CYCC

Cyclacel Pharmaceuticals, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Bio Green Med Solution, Inc. logo
    BGMS

    Bio Green Med Solution, Inc.

    Nov 12, 2025
    Award
    Direct
    200K shares at avg. $1.40$280K

1-1 of 1